Welcome to LookChem.com Sign In|Join Free
  • or
C30H31N6O13P is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

774539-74-1

Post Buying Request

774539-74-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

774539-74-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 774539-74-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,7,4,5,3 and 9 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 774539-74:
(8*7)+(7*7)+(6*4)+(5*5)+(4*3)+(3*9)+(2*7)+(1*4)=211
211 % 10 = 1
So 774539-74-1 is a valid CAS Registry Number.

774539-74-1Downstream Products

774539-74-1Relevant academic research and scientific papers

Structures of covalent adducts between DNA and ochratoxin a: A new factor in debate about genotoxicity and human risk assessment

Mantle, Peter G.,Faucet-Marquis, Virginie,Manderville, Richard A.,Squillaci, Bianca,Pfohl-Leszkowicz, Annie

, p. 89 - 98 (2010)

The potent renal carcinogenicity of ochratoxin A (OTA) in rats, principally in the male, raises questions about mechanism. Chromatographic evidence of DNA adducts after 32P-postlabeling analysis contrasts with experimental attempts to demonstrate the absence of OTA in such adducts. Proffered schemes for alternative epigenetic mechanisms in OTA carcinogenicity remain unsatisfying, while structural data substantiating DNA-OTA adducts has also been lacking. We report refined 32P-postlabeling methodology revealing one principal adduct isolated in small amounts from the kidneys of all five Fischer and five Dark Agouti rats to which OTA had been given on four consecutive days. We also describe structural data for the principal adduct from OTA/DNA interaction in vitro and its subsequent preparative isolation by the postlabeling methodology (as C-C8 OTA 3′dGMP), essentially creating an ochratoxin B - guanine adduct. Reasoning for the unsuitability of experimental protocols in published evidence claiming nongenotoxicity of OTA is given. In vivo exposure of renal DNA to cycles of adduction with OTA, necessarily protracted for carcinogenesis to occur, can reasonably explain an occasional focal neoplasm from which metastasizing carcinoma could develop.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 774539-74-1